Benzyl isothiocyanate

Benzyl isothiocyanate (CAS No.: 622-78-6) is a naturally occurring isothiocyanate phytochemical, originally identified in cruciferous plant sources, and is widely categorized as a bioactive small molecule probe for oncology, inflammation, host pathogen interaction, and metabolic mechanism research in preclinical discovery workflows. In biomedical research settings, it is primarily investigated for broad modulatory effects on apoptosis, cell cycle regulation, proliferative signaling, autophagy associated stress responses, migration and invasion related programs, and angiogenesis linked pathways, with frequently reported involvement of redox sensitive signaling networks and transcriptional control mechanisms that shape tumor cell survival and microenvironmental adaptation. Across published in vitro paradigms, activity is commonly described in the micromolar domain, often spanning low micromolar to higher micromolar ranges depending on cell lineage, exposure time, and assay endpoint, while antimicrobial or antiparasitic observations are likewise context dependent and generally evaluated over concentration intervals tailored to strain susceptibility and experimental format. This compound is therefore commonly used in cell based phenotypic assays, target deconvolution studies, and combination screening paradigms to interrogate pathway vulnerability and resistance biology, and it is also applied in animal model research addressing tumor progression, inflammatory biology, infection related responses, and metabolic dysregulation mechanisms under controlled experimental conditions. The concentrations or doses used in experiments typically depend on specific experimental designs and research objectives, and all use is restricted to laboratory research purposes rather than human use, clinical intervention, food applications, or nutritional supplementation.